2026 Q2 Portfolio Activity
In 2026 Q2, Tetragon Partners GP Ltd maintained a portfolio of 46 distinct positions. The most significant new addition was ALKAMI TECHNOLOGY INC, now representing 1.71% of the total fund value. They heavily accumulated shares in DEFINIUM THERAPEUTICS INC, increasing the position by 43.5%. The fund also reduced its exposure to WARNER BROS DISCOVERY INC by 72.9%.
Position History
hover any row below to update
Loading…
Total Positions
46
Quarter
2026 Q2
Top Holding
PATH (53.0%)
Top 10 Concentration
74.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-46 of 46
Tetragon Partners GP Ltd Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PATH
UIPATH INC
|
Technology | 52.98% | 54.32% |
#1
Prev: #1
|
8.5 |
—
|
5,742,372 | 22.8% |
P
S
|
30,950,000 | $336,426,500 |
$12.51
+32.4%
|
2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
KGEI
KOLIBRI GLOBAL ...
|
Energy | 5.33% | 7.28% |
#2
Prev: #2
|
4.6 |
—
|
no change | no change |
P
S
|
6,834,504 | $33,845,142 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AUTL
AUTOLUS THERAPE...
|
Healthcare | 2.39% | 2.55% |
#3
4
Prev: #7
|
3.0 |
—
|
no change | no change |
P
S
|
9,500,000 | $15,200,000 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
LYFT
LYFT INC
|
Technology | 2.30% | 2.58% |
#4
1
Prev: #5
|
2.4 |
—
|
no change | no change |
P
S
|
1,000,000 | $14,610,000 | 2019 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 2.13% | 0.73% |
#5
17
Prev: #22
|
3.9 |
—
|
86,996 | 43.5% |
P
S
|
286,990 | $13,500,010 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
WK
WORKIVA INC
|
Technology | 1.91% | 2.89% |
#6
2
Prev: #4
|
1.8 |
—
|
no change | no change |
P
S
|
250,000 | $12,127,500 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CXM
SPRINKLR INC
|
Technology | 1.79% | 2.56% |
#7
1
Prev: #6
|
1.7 |
—
|
no change | no change |
P
S
|
2,200,000 | $11,352,000 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 1.77% | 0.84% |
#8
13
Prev: #21
|
3.2 |
—
|
58,063 | 39.9% |
P
S
|
203,543 | $11,235,574 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ALKT
ALKAMI TECHNOLO...
|
Technology | 1.71% | — |
#9
Prev: #—
|
4.2 |
—
|
600,284 | — |
NEW
|
600,284 | $10,877,146 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.70% | 1.92% |
#10
2
Prev: #8
|
1.2 |
—
|
-21,875 | -7.0% |
P
S
|
290,441 | $10,807,310 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 1.68% | 0.35% |
#11
19
Prev: #30
|
3.7 |
—
|
388,768 | 214.1% |
P
S
|
570,311 | $10,670,519 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.67% | 1.55% |
#12
3
Prev: #9
|
1.2 |
—
|
3,286 | 2.6% |
P
S
|
130,484 | $10,635,751 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.61% | 1.22% |
#13
1
Prev: #12
|
3.1 |
—
|
74,016 | 33.4% |
P
S
|
295,627 | $10,222,782 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 1.57% | 1.10% |
#14
Prev: #14
|
2.6 |
—
|
30,188 | 18.9% |
P
S
|
189,979 | $9,953,950 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.55% | 1.05% |
#15
1
Prev: #16
|
2.6 |
—
|
37,427 | 17.1% |
P
S
|
255,934 | $9,861,137 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AXSM
CALL
AXSOME THERAPEU...
|
CALL Option | 1.35% | 1.15% |
#16
3
Prev: #13
|
1.5 |
—
|
no change | no change |
P
S
|
35,000 | $8,566,950 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 1.32% | 0.64% |
#17
9
Prev: #26
|
3.0 |
—
|
134,095 | 21.3% |
P
S
|
764,256 | $8,391,531 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.25% | 0.91% |
#18
1
Prev: #19
|
3.0 |
—
|
98,525 | 38.2% |
P
S
|
356,657 | $7,921,352 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 1.21% | 0.61% |
#19
9
Prev: #28
|
3.5 |
—
|
55,409 | 132.7% |
P
S
|
97,173 | $7,704,847 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 1.20% | 1.08% |
#20
5
Prev: #15
|
3.0 |
—
|
40,740 | 24.7% |
P
S
|
205,579 | $7,629,037 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 1.15% | 0.65% |
#21
4
Prev: #25
|
3.5 |
—
|
81,696 | 68.5% |
P
S
|
201,036 | $7,319,721 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 1.15% | 0.99% |
#22
4
Prev: #18
|
1.5 |
—
|
no change | no change |
P
S
|
19,668 | $7,310,006 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 1.12% | 1.39% |
#23
12
Prev: #11
|
0.9 |
—
|
-50,000 | -3.9% |
P
S
|
1,242,455 | $7,094,418 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CELC
CELCUITY INC
|
Healthcare | 1.06% | — |
#24
Prev: #—
|
3.9 |
—
|
64,110 | — |
NEW
|
64,110 | $6,707,188 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
WBD
WARNER BROS DIS...
|
Communication Services | 1.05% | 4.92% |
#25
22
Prev: #3
|
0.4 |
—
|
-673,725 | -72.9% |
P
S
|
250,000 | $6,665,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.96% | 1.44% |
#26
16
Prev: #10
|
0.9 |
—
|
-16,041 | -15.6% |
P
S
|
86,996 | $6,073,191 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.84% | 0.86% |
#27
7
Prev: #20
|
0.8 |
—
|
-19,951 | -6.3% |
P
S
|
297,926 | $5,350,751 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.67% | 0.62% |
#28
1
Prev: #27
|
2.3 |
—
|
23,255 | 16.1% |
P
S
|
167,875 | $4,247,238 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RARE
CALL
ULTRAGENYX PHAR...
|
CALL Option | 0.53% | — |
#29
Prev: #—
|
3.7 |
—
|
100,000 | — |
NEW
|
100,000 | $3,339,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SLN
CALL
SILENCE THERAPE...
|
CALL Option | 0.52% | — |
#30
Prev: #—
|
3.7 |
—
|
300,000 | — |
NEW
|
300,000 | $3,294,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
CUE BIOPHARMA I...
|
|
Unknown | 0.47% | — |
#31
Prev: #—
|
3.7 |
—
|
93,819 | — |
NEW
|
93,819 | $2,960,928 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
SNOW
SNOWFLAKE INC
|
Technology | 0.40% | 0.29% |
#32
1
Prev: #31
|
1.2 |
—
|
no change | no change |
P
S
|
10,000 | $2,545,000 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
KPTI
CALL
KARYOPHARM THER...
|
CALL Option | 0.39% | 0.05% |
#33
3
Prev: #36
|
3.2 |
—
|
200,300 | 400.6% |
P
S
|
250,300 | $2,445,431 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 0.33% | — |
#34
Prev: #—
|
3.6 |
—
|
400,000 | — |
NEW
|
400,000 | $2,116,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AGIO
CALL
AGIOS PHARMACEU...
|
CALL Option | 0.29% | — |
#35
Prev: #—
|
3.6 |
—
|
50,000 | — |
NEW
|
50,000 | $1,855,500 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.25% | 0.23% |
#36
3
Prev: #33
|
2.6 |
—
|
8,928 | 23.8% |
P
S
|
46,516 | $1,598,988 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 0.21% | — |
#37
Prev: #—
|
3.6 |
—
|
56,052 | — |
NEW
|
56,052 | $1,356,458 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TENX
CALL
TENAX THERAPEUT...
|
CALL Option | 0.17% | — |
#38
Prev: #—
|
3.6 |
—
|
75,100 | — |
NEW
|
75,100 | $1,092,705 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AMLX
CALL
AMYLYX PHARMACE...
|
CALL Option | 0.02% | — |
#39
Prev: #—
|
3.5 |
—
|
8,500 | — |
NEW
|
8,500 | $152,660 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 0.00% | 0.06% |
Sold All 😨
(Was: #35) |
0.0 |
—
|
-52,984 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #34) |
0.0 |
—
|
-39,473 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AARD
AARDVARK THERAP...
|
Healthcare | 0.00% | 0.23% |
Sold All 😨
(Was: #32) |
0.0 |
—
|
-316,621 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 0.00% | 0.44% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-112,115 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 0.00% | 0.66% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-20,059 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.00% | 0.66% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-102,125 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 0.00% | 1.00% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-15,952 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-46 of 46 holdings